Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, we sat down with Ruth Nicholson, Director, Global Knowledge Transfer (Neuroscience), Ipsen about the definition, challenges and emerging issues in knowledge transfer.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS Director, Mary Alice Dwyer, speaks with amir Shamim Choudry, Executive Medical Director at Sage Therapeutics, about the Single Point of Contact Model for Medical Affairs.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Bill Tidwell, Director, Field Based Medicine | Health System and Payor Strategy at Boehringer Ingelheim about engaging organized customers.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.